How is the Arcus Biosciences Inc today?

The Arcus Biosciences Inc today is trading in the green, up by 0.31% at 9.63.

How has Arcus Biosciences Inc performed historically?

The Arcus Biosciences Inc is currently trading up 0.31% on an intraday basis in the past week the index rose 5.48%. The index has been down -0.62% in the past quarter and fell -39.81% in the past year. You can view this in the overview section.

What is Arcus Biosciences Inc Annual Revenue?

Arcus Biosciences Inc Annual Revenue rose 120.51%, in the last year to $258 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Arcus Biosciences Inc Annual Net Profit?

Arcus Biosciences Inc Annual Net Profit rose 7.82% in the last year to $283 M. Its sector's average net profit growth for the last fiscal year was -13.88%.

What is Arcus Biosciences Inc Price to Earning Ratio?

Arcus Biosciences Inc Price to Earning Ratio is -2.61, which is negative.

What is Arcus Biosciences Inc Stock Price?

Arcus Biosciences Inc Stock Price fell 39.81% and underperformed its sector by 67.78% in the past year.

What is Arcus Biosciences Inc Quarterly Revenue?

Arcus Biosciences Inc Quarterly Revenue fell 80.69% YoY to $28 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Arcus Biosciences Inc Quarterly Net profit?

Arcus Biosciences Inc Quarterly Net profit fell 2,700% YoY to $112 M. Its sector's average net profit growth YoY for the quarter was -239.15%.

What is Arcus Biosciences Inc Debt to Equity Ratio?

Arcus Biosciences Inc Debt to Equity Ratio of 0.12 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Arcus Biosciences Inc Return on Equity(ROE)?

Arcus Biosciences Inc Return on Equity(ROE) for the last financial year was -59.77%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Arcus Biosciences Inc Mutual Fund Holding?

Arcus Biosciences Inc Mutual Fund Holding decreased by 0.16% in the last quarter to 35.45.

What is Arcus Biosciences Inc Promoter Share Holding?

Arcus Biosciences Inc Promoter Share Holding stayed the same in the most recent quarter at 8.1%.

What is Arcus Biosciences Inc Interest Coverage Ratio?

Arcus Biosciences Inc Interest Coverage Ratio is -69.75, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Arcus Biosciences Inc Institutional Holding?

Arcus Biosciences Inc Institutional Holding increased by 9.91% in the last quarter to 64.23.

Arcus Biosciences Inc XNYS: RCUS

Arcus Biosciences Inc Live Share Price Today, Share Analysis and Chart

Name: Arcus Biosciences Inc: Is Infosys Ltd. worth buying?
Item: Arcus Biosciences Inc
Rating: 1.17116675
Author: Trendlyne DVM scores

Momentum Trap

about

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to...

9.63 0.03 (0.31%)

49.26% Fall from 52W High

639.0K XNYS Volume

XNYS 05 Jun, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Arcus Biosciences Inc is on 10 Jun 2025 for the purpose of Arcus Biosciences Inc Annual General Meeting for 2025 See details

Low Financial Strength

16.7 / 100

Expensive Valuation

15.0 / 100

Technically Neutral

45.4 / 100

Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

1Yr Price target upside is 193%

11 analysts

Arcus Biosciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Arcus Biosciences Inc Live Share Price Today, Share Analysis and Chart

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to...

49.26% Fall from 52W High

SWOT Analysis

Arcus Biosciences Inc Live Price Chart

Arcus Biosciences Inc FAQ

How is Arcus Biosciences Inc today?

Arcus Biosciences Inc today is trading in the green, and is up by 0.31% at 9.63.

How has Arcus Biosciences Inc performed historically?

Arcus Biosciences Inc is currently trading up 0.31% on an intraday basis. In the past week the stock rose 5.48%. stock has been down -0.62% in the past quarter and fell -39.81% in the past year. You can view this in the overview section.